JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/17.01.25 Share Price

Warrant

DE000JL1KNG2

Market Closed - Börse Stuttgart 08:19:57 14/06/2024 BST
1.74 EUR +8.75% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/17.01.25
Current month-13.43%
1 month+0.58%
Date Price Change
14/06/24 1.74 +8.75%
13/06/24 1.6 -2.44%
12/06/24 1.64 +13.10%
11/06/24 1.45 0.00%
10/06/24 1.45 +3.57%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 08:19 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNG
ISINDE000JL1KNG2
Date issued 05/04/2023
Strike 225 $
Maturity 17/01/2025 (216 Days)
Parity 10 : 1
Emission price 1.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.07
Lowest since issue 1.4
Spread 0.15
Spread %8.15%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW